NFKB1 and endometrial cancer: Indeed, a study using immunohistochemical methods conducted on a group of 59 patients diagnosed with endometrial cancer, benign endometrial pathology, and with endometrial hyperplasia showed that the group with EC had significantly higher levels of NF-κB factor expression, compared to the other groups (119).